A groundbreaking shift in our drug policy has occurred, as the regulators announce the availability of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were severely restricted, but a growing body of evidence suggests they may offer aid for mental health illnesses like PTSD. This development represents a Canada mushr